A Clinical Study of 6MW3211 in Patients With Renal Cancer

Clinical trial NCT05440045 · UNKNOWN

Trial details

NCT number: NCT05440045
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Clear Cell Renal Cell Carcinoma

Start date: 2022-09-01
Primary completion: 2024-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.